National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada.
National Research stock last closed at $16.04, up 0.06% from the previous day, and has decreased 36.48% in one year. It has overperformed other stocks in the Health Information Services industry by 0.29 percentage points. National Research stock is currently +64.43% from its 52-week low of $9.76, and -40.75% from its 52-week high of $27.07.
There are currently 22.79M shares of NRC outstanding. The market capitalization of NRC is $365.48M. In the last 24 hours, 103,000 NRC shares were traded.
You need a brokerage account to access the NASDAQ market and buy NRC stock.
In our opinion, eToro is the best place to buy stocks. Here's why:
Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked the right brokerage, the next step is to fill out some personal info so you can invest in NRC today.
Now that you have filled out your info on our top ranked stock app, you can securely and quickly fund your account:
Watch this video walkthrough for more details transferring funds into your brokerage account.
After you have identified the best place to buy National Research stock, it's important to analyze their stock prior to buying, so you can wrap your head around the risk and opportunity.
WallStreetZen was built to help average investors perform more accurate fundamental analysis.
You can see all of the due diligence checks on NRC's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge NRC's true value.
Using relative valuations metrics:
You can access more valuation research on NRC's stock here.
Last year, NRC earnings were $24.21M. In the last five year, NRC's earnings have grown by -6.43% per year. This was slower than the Health Information Services industry average of 14.72%.
Last year, NRC revenue was $141.30M. Over the past 5 year, NRC's revenue has grown by 1.62% per year. This was slower than the Health Information Services industry average of 15.3%.
Find out more about NRC's earnings and revenue performance here.
Over the past 12 months, insiders at NRC have bought more shares than they have sold.
Patrick E. Beans, 10% Owner of NRC, was the latest NRC insider to buy. They bought $33,972.50 worth of NRC stock on May 12, 2025.
Dig into more about who owns NRC shares here.
National Research pays a dividend of 2.24%, compared to the Health Information Services industry's average dividend yield of 2.47%. If you owned $1,000 of NRC stock, you would have received $22.44 in the past 12 months.
National Research dividend payments have not consistently grown over the past decade and have not remained stable.
Get more info about National Research dividend yield and history here.
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
You have two main types of orders:
Click the Open button and your broker will place your order.
If you want more info about buying stocks on eToro, watch the helpful video below:
Now that you own some shares in NRC, you'll want to stay up-to-date on your company.
Create a watchlist to track the most important metrics related to your NRC stock.
To reiterate, here are the 6 steps for buying National Research stock:
If you are looking for a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get notifications regarding your investment in National Research, create your watchlist below.